According to a new report Asia-Pacific Clot Management Devices Market, published by KBV Research, the Asia-PacificClot Management Devices is expected to grow at a CAGR of 7.8% during the forecast period. The China market dominated the Asia-Pacific Clot Management for Embolectomy Balloon Catheters Market by Country in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 7.1% during the forecast period. The India market is expected to witness a CAGR of 8.4% during (2016 - 2022). Additionally, The Singapore market is expected to witness a CAGR of 8.1% during (2016 - 2022).
The Hospitals market dominated the Asia-Pacific Clot Management Market by End User in 2015, and would continue to be a dominant market till 2022; thereby, achieving a market value of $394.9 million by 2022, growing at a CAGR of 7.1% during the forecast period. The Diagnostic Centers market is expected to witness a CAGR of 10.3% during (2016 - 2022). The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the discussed region.
The key influencing factors of the Asia-PacificClot Management Devices have been discussed in the report along with the elaborated company profiles of Teleflex Inc., Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Lemaitre Vascular, Inc., Straub Medical AG, Cook Medical Inc. and Johnson & Johnson.
Full report : https://www.kbvresearch.com/asia-pacific-clot-management-devices-market/
Global Clot Management Devices Market
North America Clot Management Devices Market
Unique Offerings 
